Cognome is an independent corporation I formed in October 2018 to facilitate the adoption of my research and to advance large scale adoption of advanced analytics and digital technology in healthcare. The Pandemic interrupted our journey and we finally signed license agreements with the Montefiore Health System and the University of Texas on May 31st, 2024.
The corporation's proprietary platform marshals advanced analytics (AI/ML/DL/RL), digital technology, and data integration to re-engineer clinical practice and healthcare operations. Cognome's vision is to exploit information generated from every patient in every context to iteratively transform the healthcare sector into a continuously learning precision experience for patients, clinicians, and the systems that deliver care. At Cognome we believe that opportunities exist to create a net new market for a generation of products and services that combine technical innovation, systems integration, and public-private partnerships to transform how safely and efficiently large integrated systems deliver healthcare.
We were incubated within The Montefiore Health System which is our first customer and strategic partner. Over the past five years IntelTM, and the Montefiore Health System have partnered in several tracks of technology innovations and integration research to improve the overall performance and quality of the healthcare system. We are preparing to roll out at more large academic medical centers later this year.
Below are several links to papers and publications that highlight our technology. Separately, I will shortly be publishing a comprehensive peer reviewed paper that describes our ambitions more completely.
Peer reviewed papers explaining a selection of our AI/ML models:
Other peer-reviewed articles that are germane to our platform include:
A complete list of my peer reviewed articles can be found here.
And finally, articles that circulated in other media describing work we are doing: